AmitisGen Tech Dev Group started its endeavors as a science-based private company in 2013, after acquiring the necessary permissions from relevant authorities. AmitisGen, as a holding, aims to promote science and technology in the fields of medical biotechnology, bioinformatics, medical laboratory, vaccine, pharmacology, personalized/precision medicine, and cosmetics by employing a number of well-known experts and researchers. The aim of our group is to be the lead provider of the aforementioned services and numerous projects are ongoing to achieve these goals, including the SMARTests project with the aim of localizing genomic services. The purple color of AmitisGen (Derived from Amethyst) was selected to support Children Epilepsy Awareness activist groups.